Skip to main navigation
About Us
Leadership
Management Team
Board of Directors
Locations
Accreditations
ThermoGenesis
CAR-TXpress™
Clinical BioBanking
Point-of-Care Solutions
Cellular Processing
Clinical Pathway
Critical Limb Ischemia
Cardiovascular
OA
Investors
Stock Information
Analyst Coverage
Stock Quote/Chart
Ownership Summary
News & Events
Press Releases
Events & Webcasts
Presentations
In the News
Financial Information
SEC Filings
Financial Reports
Fundamentals
Corporate Governance
Documents
Board of Directors
Committee Composition
Contact the Board
Shareholder Services
Email Alerts
Investor Contact
Information Request
Contact Us
About Us
Leadership
Management Team
Board of Directors
Locations
Accreditations
ThermoGenesis
CAR-TXpress™
Clinical BioBanking
Point-of-Care Solutions
Cellular Processing
Clinical Pathway
Critical Limb Ischemia
Cardiovascular
OA
Investors
Stock Information
Analyst Coverage
Stock Quote/Chart
Ownership Summary
News & Events
Press Releases
Events & Webcasts
Presentations
In the News
Financial Information
SEC Filings
Financial Reports
Fundamentals
Corporate Governance
Documents
Board of Directors
Committee Composition
Contact the Board
Shareholder Services
Email Alerts
Investor Contact
Information Request
Contact Us
Loading...
INVESTORS
Press Releases
Events & Webcasts
Presentations
In the News
Press Releases
Events & Webcasts
Presentations
In the News
«
Back
Press Releases
Year:
- Any -
2019
2018
2017
2016
2015
2014
Items per page
10
25
50
February 12, 2015
Cesca therapeutics reports second quarter fiscal 2015 results
February 11, 2015
Cesca therapeutics to announce second quarter fiscal 2015 results on february 12, 2015
February 11, 2015
Cesca therapeutics announces approval of its marrowxpress(tm) system in india
February 9, 2015
Cesca therapeutics to present at 17th annual bio ceo & investor conference
January 8, 2015
Cesca therapeutics to present at biotech showcase in san francisco on january 13, 2015
January 2, 2015
Cesca receives feedback from the fda on its pivotal investigational device exemption (ide) application for treating critical limb ischemia (cli)
November 26, 2014
Cesca therapeutics invited to present at ld micro conference and the world stem cell summit
November 20, 2014
Cesca therapeutics announces filing of u.s. pivotal ide application for no-option critical limb ischemia (™cli™)
November 13, 2014
Cesca therapeutics reports first quarter fiscal 2015 results
November 12, 2014
Cesca therapeutics to announce first quarter fiscal 2015 results on november 13, 2014
Pagination
First page
First
Previous page
Previous
…
Page
14
Page
15
Current page
16
Page
17
Next page
Next
Last page
Last
Print Page
Email Alerts
Information Request
Investor Contact
RSS Feeds
